Clinical Trial Update: Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel with or without an unnamed phytochemical in breast cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Centre Jean Perrin | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED